Angiodynamics, Inc.
Clinical trials sponsored by Angiodynamics, Inc., explained in plain language.
-
Zapping liver tumors: new study tests electric pulse treatment
Disease control Not yet recruitingThis study is testing a procedure called irreversible electroporation (IRE) to treat early-stage liver cancer that hasn't spread beyond the liver. IRE uses electrical pulses to destroy tumor cells without using heat. Researchers will track how well the treatment eliminates tumors…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New device aims to suck out lung clots and save blood
Disease control Not yet recruitingThis study is testing a new medical device system designed to treat serious blood clots in the lungs. The device works by physically removing the clot and then filtering and safely returning the patient's own blood. Researchers will enroll 39 adults with recent, moderate-risk lun…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New device aims to suck deadly heart clots from patients
Disease control Not yet recruitingThis study is testing a device called the AngioVac System to see if it can safely and effectively remove dangerous clumps of infection (vegetations) from the right side of the heart in people with infective endocarditis. It will involve about 30 adult patients who have this speci…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Zapping liver tumors: new study tests electric pulse treatment
Disease control Not yet recruitingThis study is testing a procedure called irreversible electroporation (IRE) to destroy liver tumors that have spread from colorectal cancer. It will enroll 50 patients who have already received chemotherapy. Researchers will track how well the treatment eliminates tumors and moni…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC